An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for HALOZYME THERAPEUTICS Inc
| Ticker | HALO |
| FIGI | BBG000CZ8W54 |
| CUSIP | 40637H109 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 445 / 6.3% |
| Percentage held by institutional investors | 100.0% |
About
Halozyme Therapeutics is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia